Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

3C! Packaging: Added Outsert Capacity

Triple knife outsert system with new 24-plate primary folder incorporates more copy into folded leaflets of same finished size.

Triple knife outsert system with new 24-plate primary folder incorporates more copy into folded leaflets of same finished size.
Triple knife outsert system with new 24-plate primary folder incorporates more copy into folded leaflets of same finished size.

3C! Packaging, an independent, privately-owned pharmaceutical packaging company specializing in the design and manufacture of custom folding cartons, printed literature, inserts/outserts, labels/foils and unit-dose applications, has added a new 24-plate folder to its Vijuk MV-11 Triple Knife Outsert System. The system enables production of 350-panel leaflets, a 14% increase in copy space over the former 294-panel maximum.

While a typical 294 panel 1.25in. x 1.25 in. leaflet can accommodate 420 sq in. of copy per side, a 350-panel leaflet can accommodate 477 sq in. of copy per side, a significant increase as instructions, warnings and disclaimers grow ever more intricate.

The 350-fold capacity afforded by the outsert system exemplifies the company’s commitment to providing customers with the most advanced capabilities available.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?